Protocol Design White Papers & Case Studies
-
A New Blueprint For Transforming Feasibility And Recruitment
9/22/2025
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 2025
9/16/2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
-
Rethinking Lab Logistics: Delivering The Complex Without Compromise
9/10/2025
Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.
-
Engage The Right Participants Faster
9/8/2025
Clinical trial recruitment doesn’t have to be slow, costly, or unpredictable. Find the right recruit strategy and digital recruit model for your study.
-
Advancing Alzheimer's Disease Therapies
9/3/2025
By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.
-
De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital
9/3/2025
For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.
-
Enhancing Clinical Trial Flexibility
9/1/2025
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
Generate High- Quality Evidence For Pediatric Trials
9/1/2025
Generate the high-quality data required to advance safe and effective therapies for children with solutions that address the unique challenges of pediatric trials.
-
Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape
9/1/2025
Project Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
-
The Untapped Power Of Real-World Data And AI In Pharma Commercialization
8/27/2025
Harnessing RWD in commercialization bridges the gap between approval and patient access, equipping companies with actionable intelligence to deliver life-changing therapies to more patients.